Walpar Nutritions Limited

Walpar Nutritions Limited (WALPAR) is a micro-cap Healthcare company valued at ₹25 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Walpar Nutritions Limited last traded at ₹26.1, unchanged on the day.

Financial performance

The company's revenue grew 9.8% annually, reaching ₹79 crore, while net profit fell 24.5% to ₹2 crore. In the latest quarter, revenue rose 7.8% year-on-year to ₹42 crore, and net profit increased 7.9% to ₹2 crore, showing some stability in profitability.

Valuation multiples

The stock trades at 9.9 times earnings, a discount to the Healthcare median of 32.0, 1.14 times book value.

Things to watch

The company's net profit margin narrowed 1.4 percentage points to 3.1%, and it has not paid dividends despite reporting profits. The stock is 45.8% below its 52-week high, and the company's promoter holding is 68.82%, with no foreign or domestic institutional holdings.

Where it stands

The company has shown strong revenue growth over the past five years, with a 67.0% CAGR, but net profit growth has slowed, with a 24.5% annual decline. The latest quarter saw a rise in both revenue and net profit, but the stock remains significantly below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.